Philip Clarke holds the chair in Health Economics within the Centre for Health Policy at the Melbourne School of Population and Global Health, University of Melbourne. He has had previous appointments at Oxford University and the University of Sydney. He was involved in developing the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model; a computer simulation model for predicting outcomes for patients with Type 2 diabetes. He has expertise in economic evaluation alongside clinical trials, simulation modeling, measurement of health inequalities and international comparisons of drug prices. He has recently contributed to books on cost-effectiveness analysis and cost-benefit analysis published by Oxford University Press.